This paper takes stock of three cycles of health financing reform in Kyrgyzstan under three national health strategies implemented over the last 20 years.
Cardiovascular diseases (CVD) cause 50% of all deaths in Kyrgyzstan and premature mortality from CVD is still high. Clinical care of CVD is costly and prolonged